DCRI: News: Weekly News Story


Home > News > Archives > 2005 > 2005-05-18

Wednesday, May 18, 2005

The DCRI's Reed Wins New Investigator Award
By Julie McKeel

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has awarded the Bernie J. O'Brien New Investigator Award to Shelby D. Reed, PhD. Dr. Reed is the first recipient of this new award.

The ISPOR is an international non-profit organization promoting the science of pharmacoeconomics and health outcomes research. ISPOR established the ISPOR Bernie J. O’Brien New Investigator Award in 2004 to honor Dr. O’Brien’s commitment to training and mentoring new scientists in the fields of outcomes research and pharmacoeconomics. The award is given annually to the best nominee showing exceptional promise of technical and scholarly work in the field of pharmacoeconomics and outcomes research.

Shelby Reed, PhD

Dr. Reed is on the faculty of the Center for Clinical and Genetic Economics at the Duke Clinical Research Institute and is an assistant research professor in the Department of Medicine. She has a broad range of experience in planning and conducting economic and health outcome evaluations of pharmaceuticals and health care services across many different therapeutic areas, including infectious diseases, oncology, dermatology, cardiovascular disease, and cerebrovascular disease. Her methodological interests include handling and representing uncertainty in economic evaluations, hierarchical modeling, and conducting and assessing the generalizability of economic evaluations performed alongside multinational clinical trials.

Before joining the DCRI’s Center for Clinical and Genetic Economics in 2000, Dr. Reed received her PhD from the University of Maryland School of Pharmacy and completed a two-year NIH postdoctoral fellowship in the University of Washington’s Pharmaceutical Outcomes Research and Policy Program and the Center for AIDS and STDs.

The Bernie J. O'Brien New Investigator Award consists of a plaque, complimentary meeting registration, an unrestricted research grant of [U.S.] $5,000.00 and up to [U.S.] $1,500.00 for travel expenses.

Bernard J. O’Brien BA, MSc, PhD
1959-2004
Bernie J. O’Brien BA, MSc, PhD was Director of PATH and Associate Director of the Centre for Evaluation of Medicines at St. Joseph’s Hospital in Hamilton, Ontario. He was also a Professor in the Department of Clinical Epidemiology and Biostatistics, McMaster University and Director, Clinical Effectiveness Research of the Father Sean O’Sullivan Research Centre and an Associate of the Centre for Health Economics and Policy Analysis, McMaster University.